Long-term follow-up of a randomized study of combination interferon and glatiramer acetate in multiple sclerosis: Efficacy and safety results up to 7 years

Fred D. Lublin, Stacey S. Cofield, Gary R. Cutter, Tarah Gustafson, Stephen Krieger, Ponnada A. Narayana, Flavia Nelson, Amber R. Salter, Jerry S. Wolinsky

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Long-term follow-up of a randomized study of combination interferon and glatiramer acetate in multiple sclerosis: Efficacy and safety results up to 7 years'. Together they form a unique fingerprint.

Medicine & Life Sciences